Library: Webinars On-Demand

Webinars On-Demand: Diabetes

• Diabetes Recording of the Live Webinar on 17^th Oct 2024
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  Metformin – an unfinished story from Diabetes congresses 2024

  • Metformin – ADA 2024 updates
    Prof. Tamar Zerekidze, MD, PhD,
    National Institute of Endocrinology, Tbilisi, Georgia

  • News on Metformin from EASD Congress 2024
    Prof. Antonio Ceriello
    Head of Diabetes Research Department, IRCCS MultiMedica, Milan, Italy.
    Chairman EASD D&CVD Study Group

  • Q&A Interactive Session
• Diabetes Recording of the Live Webinar on 25^th Apr 2024
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  SGLT2 inhibitors and their effect on CKD in people with T2D

  • Holistic treatment of diabetic kidney disease – the role of SGLT2-inhibitors
    Prof. Per-Henric Groop, M.D. (Finland)
    Professor of Internal Medicine (Chair) at the University of Helsinki, Chief Physician of the Abdominal Center for Nephrology at the University of Helsinki and Helsinki University Hospital and Principal Investigator of the Finnish Diabetic Nephropathy Study (FinnDiane) at the Folkhälsan Research Center in Helsinki, Finland

  • Translating clinical trials into clinical practice in diabetic kidney disease
    Prof. Tomasz Stompór, M.D. (Poland)
    Head of the Department of Nephrology, Hypertensiology and Internal Diseases and the Department of Internal Diseases of University of Warmia and Mazury in Olsztyn, Poland

  • Q&A interactive session
• Diabetes Recording of the Live Webinar on 18^th Oct 2023
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  The current place of DPP4-inhibitors in diabetes treatment: insights from diabetes guidelines and clinical evidence

  • Sitagliptin update according to the recent international guidelines and studies
    Prof. Dr. Oguzhan Deyneli (Turkey)
    Koç Univ. Hast. Endokrinoloji ve Metabolizma Hast. Klinigi

  • DPP4 inhibitors: lessons of real clinical practice
    Prof. Valeh Mirzazade (Azerbaijan)
    Azerbaijan State Advanced Training Institute for Doctors named after A. Aliyev

  • Q&A interactive session
• Diabetes Recording of the Live Webinar on 20^th Sep 2023
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  Beyond glycemic control – role and importance of SGLT-2i in T2DM management

  • 2022 ADA/EASD Guidelines on diabetes management: main updates and reasons behind
    Prof. Stefano Del Prato (Italy)
    Professor of endocrinology and metabolism at the University of Pisa School of Medicine Working group member, current
    ADA/EASD Guidelines on diabetes management

  • Decoding cardioprotection with SGLT2i in type 2 diabetes
    Dr. Petar Seferovic (Serbia)
    Professor of internal medicine, University of Belgrade Working group member, current ESC/EASD Guidelines on diabetes management

  • Q&A interactive session
• Diabetes Recording of the Live Webinar on 19^th Apr 2023
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  Where Does Metformin Stand in Management of Type 2 Diabetes?

  • Metformin in the current guidelines for the treatment of diabetes
    Prof. Antonio Ceriello (Italy)
    Head of Diabetes Research Department, IRCCS MultiMedica, Milan, Italy
    Chairman EASD D&CVD Study Group

  • Metformin: from theory to clinical practice
    Prof. Elena Giorgadze (Georgia)
    Founder and Head of the Georgian National Institute of Endocrinology. Associated Professor Ivane Javakhishvili Tbilisi State University. Expert in Endocrinology at the Georgian Ministry of Health
• Diabetes Recording of the Live Webinar on 09^th Nov 2022
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  DPP-4 inhibitors: managing special populations among patients with type 2 diabetes mellitus

  • DPP-4 inhibitors for the treatment of type 2 diabetes with CKD and in the elderly patients
    Prof. Boris N. Mankovski (Ukraine)
    Head of the Department of Diabetology, National Healthcare University of Ukraine, Kiev, Ukraine

  • Diabetes and CV disease: issues and challenges from a cardiologist’s perspective
    Prof. Francesco Cosentino (Sweden)
    Professor of Cardiology Karolinska Institute Karolinska University Hospital Stockholm, Sweden
• Diabetes Recording of the Live Webinar on 25^th Mar 2022
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  DIABETIC NEUROPATHY – ESSENTIALS AND MANAGEMENT

  • Pathogenetically oriented treatment of diabetic polyneuropathy
    Prof. Dan Ziegler (Germany)
    German Diabetes Center, University of Düsseldorf

  • Current concepts in the management of symptomatic painful diabetic neuropathy
    Prof. Solomon Tesfaye (United Kingdom)
    Sheffield Teaching Hospitals and the University of Sheffield

  • Q&A interactive session
• Diabetes Recording of the Live Webinar on 10^th Nov 2021
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  Widening the scope – prevention and complication management of T2D

  • Prediabetes: does it matter and, if so, how should it be treated?
    Prof. Coen Stehouwer (Netherlands)
    Professor and Chair, Department of Internal Medicine, Maastricht University Medical Centre

  • Diabetic complications: prevention and management
    Prof. Roger Lehmann (Switzerland)
    Chief of Diabetology and Islet-transplantation, UniversitätsSpital, Zürich

  • Q&A interactive session
• Diabetes Recording of the Live Webinar on 31^st May 2021
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  Diabetes Mellitus with cardiovascular complications: from science to clinical practice

  • 1:00-1:15 pm
    Cardiovascular disease and diabetes: an overview
    Prof. Francesco Cosentino (Sweden)
    Cardiology Unit, Department of Medicine Solna, Karolinska University Hospital, Stockholm, Sweden. Vice President ESC

  • 1:15-1:30 pm
    Legacy effect of intensive glucose control on major adverse cardiovascular outcome
    Prof. Francesco Prattichizzo (Italy)
    Research Fellow, IRCCS MultiMedica Polo Scientifico e Tecnologico, Milan, Italy

  • 1:30-1:45 pm
    Metformin as a link between the gluco-cardio centric management of diabetes
    Prof. Antonio Ceriello (Italy)
    Head of Diabetes Research Department, IRCCS MultiMedica, Milan, Italy.
    Chairman EASD D&CVD Study Group

  • 1:45-2:00 pm
    Q&A Session
• Diabetes Recording of the Live Webinar on 20^th Apr 2021
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  Sitagliptin Speaker Forum / Webinar – Session 2

  • 15:00 – 15:15
    Management of type 2 diabetes mellitus
    Prof. Babek Salek Gannadi (Azerbaijan)

  • 15:15 – 15:30
    Features of the management of patients with diabetes during Ramadan
    Prof. Gulnara Rakhimova (Uzbekistan)

  • 15:30 – 15:45
    DPP4 inhibitors use in disorders of carbohydrate metabolism in combination with COVID-19
    Prof. Barno Shagazatova (Uzbekistan)

  • 15:45 – 16:00
    Q&A interactive session
• Diabetes Recording of the Live Webinar on 20^th Apr 2021
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  Sitagliptin Speaker Forum / Webinar – Session 1

  • 14:00 – 14:10
    Welcome speech
    Dr. Narmina Yusifova (HQ Berlin–Chemie/ Menarini)
    Dr. Elena Haeuser (HQ Berlin–Chemie/ Menarini)

  • 14:10 – 14:30
    Sitagliptin update according to the recent International guidelines and studies
    Prof. Dr. Oguzhan Deyneli (Turkey)

  • 14:30 – 14:45
    Q&A interactive session

  • 14:45 – 15:00
    Dipeptidyl peptidase-4 (DPP-4) inhibitors in the management of diabetes and prediabetes
    Prof. Valeh Mirza-Zade (Azerbaijan) / Associate Prof. Sadagat Sultanova (Azerbaijan)
• Diabetes Recording of the Live Webinar on 04^th Jul 2019
  

  Please login or register to watch our Webinars on demand.

  ×

  ×

  ×

  Type II diabetes in two scopes of treatment.

  • Prof. A. Ceriello (Italy): Metformin in Type II Diabetes: choice with benefits
  • Prof. E. Standl (Germany): Role of DPP4 inhibitors in Type II Diabetes treatment
  • Q&A interactive session